您的位置: 首页 > 2024年10月 第55卷 第10期 > 文字全文
2023年7月 第38卷 第7期11
目录

NIPT筛查胎儿患猫叫综合征的初探

Application of non-invasive prenatal testing for the screening of fetal Cri du Chat Syndrome

来源期刊: 广州医药 | 1122-1128 发布时间:2024-11-05 收稿时间:2025/11/13 18:44:01 阅读量:51
作者:
关键词:
无创产前检测猫叫综合征微缺失/微重复产前诊断
NIPTCri du Chat Syndromemicrodeletion/microduplicationprenatal diagnosis
DOI:
10.20223/j.cnki.1000-8535.2024.10.004
收稿时间:
2024-03-20 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 初步探讨无创产前基因检测(NIPT)筛查胎儿患猫叫综合征临床性能。方法 收集2018年4月—2019年3月行NIPT提示胎儿患猫叫综合征高风险的孕妇,并收集其羊水细胞培养染色体核型分析或微阵列芯片检测结果,分析NIPT与羊水产前诊断结果的符合率。结果 NIPT提示猫叫综合征病例11例,孕妇均接受了羊水穿刺,染色体核型分析或微阵列芯片检测出胎儿染色体异常6例,符合率为54.5%。结论 NIPT对胎儿猫叫综合征的筛查具有临床价值,当提示高风险时必须行有创性产前诊断。
Objective To investigate the value of non-invasive prenatal testing(NIPT)for the screening of fetal Cri du Chat Syndrome(CdCS). Methods Pregnant women who accepted NIPT with the results with high risk of fetal CdCS were selected in the study from April 2018 to March 2019.They were also accepted prenatal genetic counseling and the chromosome karyotype analysis or CMA detection of amniotic fluid cell culture.The coincidence rate of NIPT with chromosome karyotype and microarray analysis results were conducted. Results There were 11 cases with high risk of fetal CdCS in NIPT.All of them had received amniocentesis chromosome karyotype or microarray analysis,6(54.5%)cases were confirmed. Conclusions NIPT has some clinical value in screening fetal CdCS from maternal blood.Therefore,it was suggested to perform the invasive chromosomal karyotyping and CMA for high risk of fetal CdCS.
1、 ELDEM V,KURALAY SC,?ZDO?AN G,et al.Comprehensive analysis of circulating viral DNA in maternal plasma at population-scale using low-pass whole-genome sequencing.Genomics.2023;115(2):110556. ELDEM V,KURALAY SC,?ZDO?AN G,et al.Comprehensive analysis of circulating viral DNA in maternal plasma at population-scale using low-pass whole-genome sequencing.Genomics.2023;115(2):110556.
2、 TONG X,YU X,DU Y,et al.Peripheral Blood Microbiome Analysis via Noninvasive Prenatal Testing Reveals the Complexity of Circulating Microbial Cell-Free DNA.Microbiol Spectr.2022;10(3):e0041422. TONG X,YU X,DU Y,et al.Peripheral Blood Microbiome Analysis via Noninvasive Prenatal Testing Reveals the Complexity of Circulating Microbial Cell-Free DNA.Microbiol Spectr.2022;10(3):e0041422.
3、 FAAS BHW,ASTUTI G,MELCHERS WJG,et al.Early detection of active Human CytomegaloVirus(hCMV)infection in pregnant women using data generated for noninvasive fetal aneuploidy testing[J].EBioMedicine,2024(100):104983. FAAS BHW,ASTUTI G,MELCHERS WJG,et al.Early detection of active Human CytomegaloVirus(hCMV)infection in pregnant women using data generated for noninvasive fetal aneuploidy testing[J].EBioMedicine,2024(100):104983.
4、 ZHEN J,GU Y,WANG P,et al.Genome-wide association and Mendelian randomisation analysis among 30,699 Chinese pregnant women identifies novel genetic and molecular risk factors for gestational diabetes and glycaemic traits[J].Diabetologia,2024,67(4):703-713. ZHEN J,GU Y,WANG P,et al.Genome-wide association and Mendelian randomisation analysis among 30,699 Chinese pregnant women identifies novel genetic and molecular risk factors for gestational diabetes and glycaemic traits[J].Diabetologia,2024,67(4):703-713.
5、 唐国一,杨红梅,杨恺欣,等.GDM患者妊娠中期血糖异常项数及妊娠晚期血糖指标与妊娠结局的关系[J].广州医药,2024,55(3):316-323. 唐国一,杨红梅,杨恺欣,等.GDM患者妊娠中期血糖异常项数及妊娠晚期血糖指标与妊娠结局的关系[J].广州医药,2024,55(3):316-323.
6、 CASTRO C P D,GóMEZ-GONZáLEZ C,RODRíGUEZ-LóPEZ R,et al.Prenatal diagnosis commission and the genetics commission of the Spanish society of laboratory medicine.Prenatal genetic diagnosis of monogenic diseases[J].Adv Lab Med.2023;4(1):28-51. CASTRO C P D,GóMEZ-GONZáLEZ C,RODRíGUEZ-LóPEZ R,et al.Prenatal diagnosis commission and the genetics commission of the Spanish society of laboratory medicine.Prenatal genetic diagnosis of monogenic diseases[J].Adv Lab Med.2023;4(1):28-51.
7、 WANG C,MEI L,WAN Y,et al.Clinical value of positive CNVs results by NIPT without fetal ultrasonography-identified structural anomalies[J].Mol Genet Genomic Med,2024,12(1):e2352. WANG C,MEI L,WAN Y,et al.Clinical value of positive CNVs results by NIPT without fetal ultrasonography-identified structural anomalies[J].Mol Genet Genomic Med,2024,12(1):e2352.
8、 TIAN W,YUAN Y,YUAN E,et al.Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication[J].Eur J Med Res,2023,28(1):304. TIAN W,YUAN Y,YUAN E,et al.Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication[J].Eur J Med Res,2023,28(1):304.
9、 ZHANG M,TANG J,LI J,et al.Value of noninvasive prenatal testing in the detection of rare fetal autosomal abnormalities[J].Eur J Obstet Gynecol Reprod Biol,2023(284):5-11. ZHANG M,TANG J,LI J,et al.Value of noninvasive prenatal testing in the detection of rare fetal autosomal abnormalities[J].Eur J Obstet Gynecol Reprod Biol,2023(284):5-11.
10、 ZOU Y,FENG C,QIN J,et al.Performance of expanded non-invasive prenatal testing for fetal aneuploidies and copy number variations:A prospective study from a single center in Jiangxi province,China[J].Front Genet,2022(13):1073851. ZOU Y,FENG C,QIN J,et al.Performance of expanded non-invasive prenatal testing for fetal aneuploidies and copy number variations:A prospective study from a single center in Jiangxi province,China[J].Front Genet,2022(13):1073851.
11、 ZHANG F,YIN T,TANG X,et al.Prenatal diagnosis of a case with complete and uniform tetrasomy 12p by the utility of noninvasive prenatal testing[J].J Assist Reprod Genet,2023,40(9):2233-2240. ZHANG F,YIN T,TANG X,et al.Prenatal diagnosis of a case with complete and uniform tetrasomy 12p by the utility of noninvasive prenatal testing[J].J Assist Reprod Genet,2023,40(9):2233-2240.
12、 YUAN X,YONG W,DAI L,et al.The role of non-invasive prenatal testing and ultrasound in prenatal screening of fetal chromosomal abnormalities in singleton:A retrospective study[J].Ann Transl Med,2023,11(2):111. YUAN X,YONG W,DAI L,et al.The role of non-invasive prenatal testing and ultrasound in prenatal screening of fetal chromosomal abnormalities in singleton:A retrospective study[J].Ann Transl Med,2023,11(2):111.
13、 DEL G F,YIN Y,CHOUFANI S,et al.Genomic imbalances in the placenta are associated with poor fetal growth[J].Mol Med,2021,27(1):3. DEL G F,YIN Y,CHOUFANI S,et al.Genomic imbalances in the placenta are associated with poor fetal growth[J].Mol Med,2021,27(1):3.
14、 DEL G F,YUAN V,ROBINSON W P.Confined placental mosaicism involving multiple de novo copy number variants associated with fetal growth restriction:A case report[J].Am J Med Genet A,2021,185(6):1908-1912. DEL G F,YUAN V,ROBINSON W P.Confined placental mosaicism involving multiple de novo copy number variants associated with fetal growth restriction:A case report[J].Am J Med Genet A,2021,185(6):1908-1912.
15、 MARDY A,WAPNER R J.Confined placental mosaicism and its impact on confirmation of NIPT results[J].Am J Med Genet C Semin Med Genet,2016,172(2):118-122. MARDY A,WAPNER R J.Confined placental mosaicism and its impact on confirmation of NIPT results[J].Am J Med Genet C Semin Med Genet,2016,172(2):118-122.
16、 SUZUMORI N,SEKIZAWA A,TAKEDA E,et al.Retrospective details of false-positive and false-negative results in non-invasive prenatal testing for fetal trisomies 21,18 and 13[J].Eur J Obstet Gynecol Reprod Biol,2021(256):75-81. SUZUMORI N,SEKIZAWA A,TAKEDA E,et al.Retrospective details of false-positive and false-negative results in non-invasive prenatal testing for fetal trisomies 21,18 and 13[J].Eur J Obstet Gynecol Reprod Biol,2021(256):75-81.
17、 PENG Y,PANG J,HU J,et al.Clinical and molecular characterization of 12 prenatal cases of Cri-du-chat syndrome[J].Mol Genet Genomic Med,2020,8(8):e1312. PENG Y,PANG J,HU J,et al.Clinical and molecular characterization of 12 prenatal cases of Cri-du-chat syndrome[J].Mol Genet Genomic Med,2020,8(8):e1312.
18、 AMBERGER J S,BOCCHINI C A,SCOTT A F,et al.OMIM.org:Leveraging knowledge across phenotype-gene relationships[J].Nucleic Acids Res,2019,47(D1):D1038-D1043. AMBERGER J S,BOCCHINI C A,SCOTT A F,et al.OMIM.org:Leveraging knowledge across phenotype-gene relationships[J].Nucleic Acids Res,2019,47(D1):D1038-D1043.
19、 DENNIS LO Y M.Noninvasive fetal whole-genome sequencing from maternal plasma:Feasibility studies and future directions[J].Clin Chem,2013,59(4):601-603. DENNIS LO Y M.Noninvasive fetal whole-genome sequencing from maternal plasma:Feasibility studies and future directions[J].Clin Chem,2013,59(4):601-603.
20、 LO Y M,CORBETTA N,CHAMBERLAIN P F,et al.Presence of fetal DNA in maternal plasma and serum[J].Lancet,1997,350(9076):485-487. LO Y M,CORBETTA N,CHAMBERLAIN P F,et al.Presence of fetal DNA in maternal plasma and serum[J].Lancet,1997,350(9076):485-487.
21、 CHIU R W,AKOLEKAR R,ZHENG Y W,et al.Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing:Large scale validity study[J].BMJ,2011(342):c7401. CHIU R W,AKOLEKAR R,ZHENG Y W,et al.Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing:Large scale validity study[J].BMJ,2011(342):c7401.
22、 LIAO C,YIN A H,PENG C F,et al.Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing[J].Proc Natl Acad Sci USA,2014,111(20):7415-7420. LIAO C,YIN A H,PENG C F,et al.Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing[J].Proc Natl Acad Sci USA,2014,111(20):7415-7420.
23、 YIN A H,PENG C F,ZHAO X,et al.Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA[J].Proc Natl Acad Sci USA,2015,112(47):14670-14675. YIN A H,PENG C F,ZHAO X,et al.Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA[J].Proc Natl Acad Sci USA,2015,112(47):14670-14675.
24、 SHI P,WANG Y,LIANG H,et al.The potential of expanded noninvasive prenatal screening for detection of microdeletion and microduplication syndromes[J].Prenat Diagn,2021,41(10):1332-1342. SHI P,WANG Y,LIANG H,et al.The potential of expanded noninvasive prenatal screening for detection of microdeletion and microduplication syndromes[J].Prenat Diagn,2021,41(10):1332-1342.
25、 LIANG D,CRAM D S,TAN H,et al.Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes[J].Genet Med,2019,21(9):1998-2006. LIANG D,CRAM D S,TAN H,et al.Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes[J].Genet Med,2019,21(9):1998-2006.
26、 HU H,WANG L,WU J,et al.Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies[J].Hum Genomics,2019,13(1):14. HU H,WANG L,WU J,et al.Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies[J].Hum Genomics,2019,13(1):14.
27、 SRINIVASAN A,BIANCHI D W,HUANG H,et al.Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma[J].Am J Hum Genet,2013,92(2):167-176. SRINIVASAN A,BIANCHI D W,HUANG H,et al.Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma[J].Am J Hum Genet,2013,92(2):167-176.
28、 LIU Y,LIU H,HE Y,et al.Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21,18,13 and sex chromosome aneuploidy in a pilot city in China[J].Hum Genomics,2020,14(1):21. LIU Y,LIU H,HE Y,et al.Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21,18,13 and sex chromosome aneuploidy in a pilot city in China[J].Hum Genomics,2020,14(1):21.
29、 HU H,LIU H,PENG C,et al.Clinical experience of non-invasive prenatal chromosomal aneuploidy testing in 190,277 patient samples[J].Curr Mol Med,2016,16(8):759-766. HU H,LIU H,PENG C,et al.Clinical experience of non-invasive prenatal chromosomal aneuploidy testing in 190,277 patient samples[J].Curr Mol Med,2016,16(8):759-766.
30、 HIGURASHI M,ODA M,ⅡJIMA K,et al.Livebirth prevalence and follow-up of malformation syndromes in 27,472 newborns[J].Brain Dev,1990,12(6):770-773. HIGURASHI M,ODA M,ⅡJIMA K,et al.Livebirth prevalence and follow-up of malformation syndromes in 27,472 newborns[J].Brain Dev,1990,12(6):770-773.
31、 CERRUTI MAINARDI P.Cri du Chat syndrome[J].Orphanet J Rare Dis,2006(1):33. CERRUTI MAINARDI P.Cri du Chat syndrome[J].Orphanet J Rare Dis,2006(1):33.
32、 LEJEUNE J,LAFOURCADE J,BERGER R,et al.3 cases of partial deletion of the short arm of a 5 chromosome[J].C R Hebd Seances Acad Sci,1963(257):3098-3102. LEJEUNE J,LAFOURCADE J,BERGER R,et al.3 cases of partial deletion of the short arm of a 5 chromosome[J].C R Hebd Seances Acad Sci,1963(257):3098-3102.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录